#

Ulcerative Colitis (InDex)

  • Compensation to be determined
  • 13 visits (enrollment open)
#

18+ Years

#
Male or Female
#
Smoker & Non-Smoker

Description

A Randomized Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance Therapy in Participants with Moderate to Severe Active Left-Sided Ulcerative Colitis.

Is this not what you are looking for?
Check out our other studies.

Related Studies

#

COPD

  • Compensation to be determined
  • 12 clinic visits
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
#

Chronic Idiopathic Urticaria

  • Compensation to be determined
  • 13 clinic visits including 3 safety follow-up visits
#
Between 18 - 75 Years

#
Male or Female
#
Smoker & Non-Smoker
#

Ulcerative Colitis (IQVIA)

  • Compensation to be determined
  • clinic visits 10
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
© 2023 Access Research Institute. All Rights Reserved